Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Amniotic Membrane Extract Eye Drops as an Adjunctive Therapy in Resistant Corneal Ulcers: A Randomized Clinical Trial Study

NCT06909149 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06909149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06909149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Amniotic Membrane Extract Eye Drops as an Adjunctive Therapy in Resistant Corneal Ulcers: A Randomized Clinical Trial Study
Lead sponsor
Tanta University
Phase
Not applicable
Overall status
Completed
Start date
May 1, 2019
Completion date
May 1, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amniotic membrane extract eye drops, resistant corneal ulcers